U.S. & ASIA PACIFIC PORTABLE MEDICAL OXYGEN CONCENTRATORS MARKET ANALYSIS

U.S. & Asia Pacific Portable Medical Oxygen Concentrators Market, by Technology (Pulse Flow, Continuous Flow), by Application (Chronic obstructive pulmonary disease (COPD), Asthma, Respiratory Distress Syndrome, Others), by End User (Hospitals, Homecare Settings, Ambulatory Surgical Centers, Others), and by Region/country (U.S. and Asia Pacific) Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

Published In : Nov 2022
Code : CMI5370
Pages :220
Formats :
Excel and PDF
Industry : Medical Devices

Market Challenges And Opportunities

U.S. & Asia Pacific Portable Medical Oxygen Concentrators Market – Drivers

Increasing prevalence of respiratory disorders is expected to fuel growth For instance, according to data published in AME Publishing Company, a globally active open access publisher, in April 2021, the overall prevalence of COPD in the general population aged ≥40 years was around 10% in Japan in 2020

U.S. & Asia Pacific Portable Medical Oxygen Concentrators Market-Restraint

Product recalls for portable medical oxygen systems is expected to hamper the U.S. & Asia Pacific portable oxygen concentrator market growth. Therefore, increasing recalls may affect the production capacities of manufacturers and distribution chains. For instance, in March 25, 2022, the U.S. FDA announced the recall of CAIRE FreeStyle Comfort Portable Oxygen Concentrator with autoSAT, UltraSense, and autoDOSE, model. Manufacturer’s reason for recall is the device was not cleared for the U.S. distribution. The recalling firm initially contacted the customers via voicemail and email on March 25, 2022. The email informed the consignee that the two affected units that were shipped to them could not be sold in the U.S. or its territories due to the FDA approval.